Trial Profile
Phase I tolerability and pharmacokinetic study of Lu AF11167.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 30 Mar 2011
Price :
$35
*
At a glance
- Drugs Lu AF11167 (Primary)
- Indications Alzheimer's disease; Huntington's disease; Schizophrenia
- Focus Adverse reactions; Pharmacokinetics
- 30 Mar 2011 New trial record